Inhalation and Respiratory Drug Products Summit
28-29

September 2017

Germany

Berlin

Hotel Riu Plaza Berlin

Martin-Luther-Straße 1, 10777

About

Vonlanthen Group of Companies will be presenting a conference that includes a multitude of different subjects within the field of Inhalation and Respiratory Drug Development. We will be discussing how we develop and design dry powder inhalers; integrate development and scale-up combination products; patient use, compliance and human factors associated with DPIs; the challenges of developing a generic inhalant product; and the analytical approaches and specifications for inhaled medicine. Our panel will be addressing these critical issues and...

Vonlanthen Group of Companies will be presenting a conference that includes a multitude of different subjects within the field of Inhalation and Respiratory Drug Development. We will be discussing how we develop and design dry powder inhalers; integrate development and scale-up combination products; patient use, compliance and human factors associated with DPIs; the challenges of developing a generic inhalant product; and the analytical approaches and specifications for inhaled medicine. Our panel will be addressing these critical issues and much more over the two days, to drive new concepts and new ways of thinking among a consortium of different companies and people in the field of Respiratory and Inhalation Drug/Product Development. We hope to see you in Berlin this coming September 2017!

more info
Who Should Attend

Directors, Vice Presidents, Managers and Department Heads specialising in:

  • Respiratory Drug Development
  • Scientific Research
  • Inhalation Drug Delivery Inhalation Device Development and Engineering
  • Medical Devices & Injectors
  • Inhalation Product Development
  • Medical Marketing
  • Device Engineering New Delivery Technologies
  • Inhaled Dosage Systems Connective Health
  • Pulmonary Disease Metered Dose Inhaler Development
  • Respiratory Medicine Inhalation
  • Generics & Respiratory
  • Drug Delivery Innovation Respiratory Pharmacology
  • Inhalation Formulation Development
  • Inhalation Process Development Particle Characterisation
  • Marketing and Business Development
  • E-health Inhalation Drug Delivery Technologies
  • Respiratory Regulations Respiratory R&D
Key Practical Learning Points of the Summit

Regulatory updates in the global respiratory market
Innovative technologies for inhalation delivery
Enhancing the performance of DPI
Integrate development and scale-up combination products
Device and formulation integration
Integrated formulation design approaches for DPI
Analytical approaches and specifications
Human factors: Design, planning and implementation
Speakers
Dr. Frank Thielmann

PMO & Operational Excellence Platform Leader, Biologics

Novartis

Dr. John Pritchard

Director PMO & Technology, Resp. Drug Delivery, Sleep & Resp. Care

Philips

Paul Johnson, UK

Inhaled Product Platform Lead

GSK R&D

Elisa Le Floch, FR

Business Development & Marketing Manager

Clariant

Iris Erez, IL

Associate Director Marketing – Respiratory

Teva

Dr. Stefan Leiner

Quality + Records Management

Boehringer Ingelheim

Sam Van Alstyne, USA

New Products Marketing Manager

3M Drug Delivery Systems Division

Dr. Holger Memmesheimer

Quality Pharmaceutical + Chem. Manuf.

Boehringer Ingelheim

Paul Smith, UK

Functional Manager, Inhalation Toxicology

Charles River Laboratories Edinburgh Ltd.

Dr. Gerhard Scheuch

CEO

GS BIO-INHALATION

Dr. João Ventura Fernandes, PT

Business Development Manager

Hovione Technology

Dr. Sven Stegemann

Professor for Patient Centric Drug Development and Manufacturing Graz University of Technology & Director, Pharmaceutical Business Development

Capsugel

Annual

Events

Sponsors and Partners

Partner

Media partner

Media partner

Media partner

Media partner

Media partner

Media partner

Media partner

Media partner